(Q40350738)

English

Second-generation replication-competent oncolytic adenovirus armed with improved suicide genes and ADP gene demonstrates greater efficacy without increased toxicity

scientific article published on 14 November 2005

In more languages

Statements

scholarly article

1 reference

19 September 2017

Second-generation replication-competent oncolytic adenovirus armed with improved suicide genes and ADP gene demonstrates greater efficacy without increased toxicity (English)

1 reference

19 September 2017

0 references

oncolytic virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Kenneth N Barton

1

1 reference

19 September 2017

Dell Paielli

2

1 reference

19 September 2017

Yingshu Zhang

3

1 reference

19 September 2017

Sweaty Koul

4

1 reference

19 September 2017

Stephen L Brown

5

1 reference

19 September 2017

Mei Lu

6

1 reference

19 September 2017

John Seely

7

1 reference

19 September 2017

Jae Ho Kim

8

1 reference

19 September 2017

Svend O Freytag

9

1 reference

19 September 2017

publication date

14 November 2005

1 reference

19 September 2017

Molecular Therapy

1 reference

19 September 2017

13

1 reference

19 September 2017

347-356

1 reference

19 September 2017

2

1 reference

19 September 2017

Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.005

7 January 2021

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.005

7 January 2021

Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.005

7 January 2021

Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.005

7 January 2021

A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.005

7 January 2021

A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.005

7 January 2021

Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.005

7 January 2021

Efficacy and toxicity of replication-competent adenovirus-mediated double suicide gene therapy in combination with radiation therapy in an orthotopic mouse prostate cancer model

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.005

7 January 2021

Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.005

7 January 2021

Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.005

7 January 2021

Enzyme/prodrug therapy for head and neck cancer using a catalytically superior cytosine deaminase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.005

7 January 2021

Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.005

7 January 2021

The E3-11.6-kDa adenovirus death protein (ADP) is required for efficient cell death: characterization of cells infected with adp mutants

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.005

7 January 2021

Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.005

7 January 2021

Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.005

7 January 2021

Radiation increases the activity of oncolytic adenovirus cancer gene therapy vectors that overexpress the ADP (E3-11.6K) protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.005

7 January 2021

GENIS: gene expression of sodium iodide symporter for noninvasive imaging of gene therapy vectors and quantification of gene expression in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.005

7 January 2021

A quantitative method for measuring gene expression magnitude and volume delivered by gene therapy vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.005

7 January 2021

Identifiers

10.1016/J.YMTHE.2005.10.005

1 reference

19 September 2017

1 reference

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40350738&oldid=1895973284"